相关实验视频

Updated: Jun 30, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

刺激激活重新编程微环境,使其对NF1相关的恶性外围神经膜瘤进行免疫治疗

Bandarigoda N Somatilaka¹, Laasya Madana¹, Ali Sadek¹

¹Department of Dermatology.

The Journal of clinical investigation

|March 19, 2024

概括

激活STING信号转化冷恶性外围神经膜瘤 (MPNSTs) 成为热瘤. 在临床前模型中,将STING激动剂与免疫检查点阻塞 (ICB) 结合起来,延迟了MPNST的生长.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

神经纤维素瘤类型1 (NF1) 涉及NF1基因突变,导致RAS过活化和诸如恶性外围神经膜瘤 (MPNSTs) 等瘤.
MPNSTs具有攻击性,难以使用当前疗法治疗,并且是NF1患者死亡的主要原因.
免疫检查点阻塞 (ICB) 对无法治疗的癌症有希望,但需要炎症瘤微环境,而MPNST通常缺乏这种微环境.

研究的目的:

研究IFN基因激活刺激器 (STING) 信号是否可以将MPNST转化为T细胞炎症"热"瘤.
评估将STING激活与ICB作为MPNST的潜在治疗方法的有效性.

主要方法:

利用了小鼠遗传和人类异种移植MPNST模型.
在免疫检查点阻塞 (ICB) 组合下服用一种STING激动剂.

主要成果:

刺激激活成功地将MPNST从"冷"转化为"热"瘤,增加T细胞透.
在小鼠遗传和人类异种移植模型中,STING激动剂和ICB的联合治疗显著延迟了瘤生长.
观察到的瘤生长延迟与瘤内的亡细胞死亡增加有关.

结论:

激活STING信号是一种可行的策略,可以增强MPNSTs的免疫性.
将STING激动剂与ICB结合起来,是治疗NF1患者的MPNST的一种有前途的治疗方法.
这一战略为MPNST提供了潜在的新治疗方案,解决了他们目前对标准疗法的耐药性.

关键词:

癌症免疫疗法癌症免疫疗法免疫治疗是一种免疫疗法.在瘤学瘤学.治疗方法治疗方法

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.